Ignite Creation Date:
2024-05-06 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 2:17 PM
Study NCT ID:
NCT05114902
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-09-13
First Post:
2021-10-29
Brief Title:
PCV13 Impact on Pneumococcal Nasopharyngeal Carriage Study
Sponsor:
Asian Foundation for Tropical Medicine Inc
Organization:
Asian Foundation for Tropical Medicine Inc
Study Overview
Official Title:
Assessing the Impact of PCV13 on Pneumococcal Nasopharyngeal Colonization in Children 8 Weeks to 60 Months of Age Hospitalized for Pneumonia in the Philippines
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IMPACT
Brief Summary:
Prospective observational hospital based nasopharyngeal carriage NPC vaccine effectiveness study Comparisons will be made in Filipino children aged 8 weeks to 60 months of age at enrollment who have been hospitalized with a radiologically-confirmed community-acquired pneumonia CAP
Detailed Description:
This study will be the first of two phases A and B Phase A will compare a PCV13-vaccinated setting SPMC with an unvaccinated setting PCMC
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None